(Iso)-Dehydroemetine

CAS No. 2649-50-5

(Iso)-Dehydroemetine( —— )

Catalog No. M36071 CAS No. 2649-50-5

(Iso)-Dehydroemetine (Dehydroisoemetine, (+/-)-) is a compound with antispasmolytic effect on smooth muscle.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 340 Get Quote
5MG 273 Get Quote
10MG 372 Get Quote
25MG 563 Get Quote
50MG 742 Get Quote
100MG 977 Get Quote
200MG 1293 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (Iso)-Dehydroemetine
  • Note
    Research use only, not for human use.
  • Brief Description
    (Iso)-Dehydroemetine (Dehydroisoemetine, (+/-)-) is a compound with antispasmolytic effect on smooth muscle.
  • Description
    (Iso)-Dehydroemetine (Dehydroisoemetine, (+/-)-) is a compound with antispasmolytic effect on smooth muscle.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2649-50-5
  • Formula Weight
    478.62
  • Molecular Formula
    C29H38N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C=1C[C@]2(C=3C(=CC(OC)=C(OC)C3)CCN2CC1CC)[H])[C@H]4C=5C(=CC(OC)=C(OC)C5)CCN4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 3,4 Dichloroisocouma...

    3,4 Dichloroisocoumarin is a granzyme, cathepsin G, and neutrolphil elastase inhibitor.

  • BDC2.5 mimotope 1040...

    This is a effectively agonistic peptide (mimotope) for diabetogenic T cell clone BDC2.5. It can stimulate BDC2.5 cells with cells showing good response to this mimotope. 1040-31 peptide is specific for BDC2.5 TCR Tg+ (transgenic) T cells. This peptide is also known as p31.

  • Moschamine

    Moschamine is a very potent compound that is able to inhibit COX-I by 58% and COX-II by 54%, at the concentration of 0.1 μmol L⁻1, it may suppress cAMP formation via binding to 5-HT1 receptors in the cells. Moschamine exerts antitumour effects on HeLa, MCF7 and A431 cells.